Baylor Scott & White Research Institute scientists found curcumin, a plant-based medicinal compound, can help overcome chemotherapy resistance in pancreatic ductal adenocarcinoma, the country’s fourth leading cause of cancer-related deaths.
According to researchers, resistance to chemotherapeutic drugs is a major challenge for PDAC patients. Initially, patients may respond to chemotherapy but, as cancer stem cells form, patients’ bodies may become immune to chemotherapy drugs. Read more . . .http://healthcare.dmagazine.com/2017/08/03/baylor-scott-white-research-shows-curcumin-protects-against-chemoresistant-pancreatic-cancer-draft/